SARS-CoV-2, the virus responsible for the COVID-19 pandemic, has wreaked havoc across the globe for the last two years. More than 300 million cases and over 5 million deaths later, we continue battling the first real pandemic of the 21st century. SARS-CoV-2 spread quickly, reaching most countries within the first half of 2020, and New Zealand was not an exception. Here, we describe the first isolation and characterization of SARS-CoV-2 variants during the initial virus outbreak in New Zealand. Patient-derived nasopharyngeal samples were used to inoculate Vero cells and, three to four days later, a cytopathic effect was observed in seven viral cultures. Viral growth kinetics was characterized using Vero and VeroE6/TMPRSS2 cells. The identity of the viruses was verified by RT-qPCR, Western blot, indirect immunofluorescence assays, and electron microscopy. Whole-genome sequences were analyzed using two different yet complementary deep sequencing platforms (MiSeq/Illumina and Ion PGM™/Ion Torrent™), classifying the viruses as SARS-CoV-2 B.55, B.31, B.1, or B.1.369 based on the Pango Lineage nomenclature. All seven SARS-CoV-2 isolates were susceptible to remdesivir (EC 50 values from 0.83 to 2.42 µM) and β-D-N 4 -hydroxycytidine (molnupiravir, EC 50 values from 0.96 to 1.15 µM) but not to favipiravir (>10 µM). Interestingly, four SARS-CoV-2 isolates, carrying the D614G substitution originally associated with increased transmissibility, were more susceptible (2.4-fold) to a commercial monoclonal antibody targeting the spike glycoprotein than the wild-type viruses. Altogether, this seminal work allowed for early access to SARS-CoV-2 isolates in New Zealand, paving the way for numerous clinical and scientific research projects in the country, including the development and validation of diagnostic assays, antiviral strategies, and a national COVID-19 vaccine development program.
【저자키워드】 COVID-19, whole-genome sequencing, SARS-CoV-2, Antiviral, virus isolate, New Zealand, 【초록키워드】 viruses, pandemic, molnupiravir, COVID-19 pandemic, monoclonal antibody, spike glycoprotein, SARS-CoV-2 variant, diagnostic, Remdesivir, Favipiravir, virus, Spread, RT-qPCR, electron microscopy, Viral, Transmissibility, SARS-CoV-2 variants, cells, outbreak, western blot, Microscopy, Research, Isolation, death, whole-genome sequences, immunofluorescence, platform, Cytopathic effect, deep sequencing, Vero, MiSeq, B.1, complementary, indirect immunofluorescence, (molnupiravir, characterization, identity, Antiviral strategies, COVID-19 vaccine development, growth, sequence, Vero cells, wild-type, cultures, SARS-CoV-2 isolates, National, D614G substitution, Vero Cell, nasopharyngeal sample, susceptible, country, Seven, initial, responsible, analyzed, globe, assays, characterized, were used, Ion, New, SARS-CoV-2 isolate, 【제목키워드】 response, Rapid, isolate, New, Part,